COVID-19's Effect On Life Science Litigation

By Laurie Mims & Bailey Heaps

Editor’s note: This article was written in June 2020.

While the world’s eyes are trained on whether and when the life sciences industry is going to develop treatments and ultimately a vaccine for COVID-19, the press of ordinary business continues, and contractual obligations that arose in what now feels like a former life generally remain.